Member Groups

Health Care LawThe newsletter of the ISBA’s Section on Health Care Law

Browse articles by year: 2014 (2) 2013 (8) 2012 (9) 2011 (8) 2010 (8) 2009 (8) 2008 (10) 2007 (9) 2006 (10) 2005 (12) 2004 (9) 2003 (13) 2002 (9) 2001 (7) 2000 (10) 1999 (10)

Newsletter articles from 2009

All the latest developments in health care law By W. Eugene Basanta and Jennifer Wagner December 2009  Health care-related cases and decisions.
All the latest developments in health care law By W. Eugene Basanta September 2009 Recent cases of interest to health care practitioners.
All the latest developments in health care law By W. Eugene Basanta and Brittany Ledbetter June 2009 Recent cases of interest to health care practitioners.
All the latest developments in health care law By W. Eugene Basanta and Brittany Ledbetter March 2009 Recent cases of interest to health care practitioners.
Changing landscape of physician-industry relationships: A trend toward transparency By Fatema Zanzi March 2009 During the past year, there has been a frenzy of activity responding to the specific demand for transparency in relationships between physicians and industry groups, which are believed to contribute to the exorbitant cost of healthcare.
Illinois Medical Fee Splitting Statute amended to allow percentage billing contracts By Rick L. Hindmand December 2009 On August 24, 2009, Illinois Governor Patrick Quinn approved Public Act 96-0608, which amended the fee splitting prohibitions of the Illinois Medical Practice Act and the Illinois Optometric Practice Act to allow percentage billing contracts and to provide additional detail regarding the scope of the prohibitions.
Medicare: Improvements needed to address improper payments in home health June 2009 Concerns have been raised that improper payments from practices indicating fraud and abuse may have contributed to Medicare home health spending and utilization.
Shortcomings in FDA’s premarket review, postmarket surveillance, and inspections of device manufacturing establishments September 2009 In 2009, GAO added FDA’s oversight of medical products, including devices, to its list of high-risk areas warranting attention by Congress and the executive branch.